Generated by AI
RenovoRx, Inc. is a life sciences company focused on targeted oncology therapies and localized drug delivery for cancer treatment. Its core offering includes RenovoCath, an FDA-cleared local drug delivery device designed to deliver chemotherapy directly to tumor sites while limiting exposure to healthy tissue. The company also develops its Trans-Arterial Micro-Perfusion therapy platform, which is intended for precise intra-arterial delivery of cancer treatments in solid tumors. RenovoRx’s work centers on addressing high unmet medical needs in oncology, with particular emphasis on improving how therapies are administered in clinical settings. The company operates at the intersection of medical technology and biopharmaceutical development, serving the broader cancer care market through device-enabled drug delivery solutions.
Website2570 West El Camino Real
Mountain View, CA, 94040
United States
The latest articles about RNXT.
Summary of Oct 14's posts. Generated by AI.
Summary of Aug 15's posts. Generated by AI.
Summary of Sep 9's posts. Generated by AI.
Investors talking about RNXT also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.